Page last updated: 2024-09-05

erlotinib hydrochloride and Pancoast Syndrome

erlotinib hydrochloride has been researched along with Pancoast Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clause, AL; Pieters, T; Vanderheyde, K	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Pancoast Syndrome

Article	Year
[Safety of reintroduction of erlotinib at low doses following hand-foot syndrome induced by erlotinib treatment for a Pancoast-Tobias tumour]. Revue des maladies respiratoires, 2014, Volume: 31, Issue:7 Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Erlotinib Hydrochloride; Hand-Foot Syndrome; Humans; Lung Neoplasms; Male; Pancoast Syndrome; Protein Kinase Inhibitors; Quinazolines; Retreatment	2014

Article

Year

[Safety of reintroduction of erlotinib at low doses following hand-foot syndrome induced by erlotinib treatment for a Pancoast-Tobias tumour].

Revue des maladies respiratoires, 2014, Volume: 31, Issue:7

Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Erlotinib Hydrochloride; Hand-Foot Syndrome; Humans; Lung Neoplasms; Male; Pancoast Syndrome; Protein Kinase Inhibitors; Quinazolines; Retreatment

2014